AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Nurse-led Physician-supported Care for Patients With Chronic Kidney Disease and Multimorbidity

RecruitingNAAges 21 Years - anyAllAlexandra Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Chronic kidney disease (CKD) is a prevalent chronic disease and is often intertwined with the management of cardiovascular disease and the optimization of metabolic risk factors. In light of steeply rising rates of end-stage kidney disease (ESKD) and increased healthcare resource utilization by CKD patients, the investigators propose that the role of nurses could be expanded to support the care of CKD patients in the community. A total of 220 patients will be randomized (1:1) to the intervention or control groups (usual care). The intervention entails enrolment into a nurse-led, physician-supported programme (INTEGREAT-CKD), comprising outpatient consultations and community-based ambulatory monitoring and counselling primarily driven by CKD-trained advanced practice nurses (APNs) and healthcare professionals conducted over 6 months. Patient-reported outcomes like health-related quality

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria : * Adults aged 21 years and above AND diagnosed with * CKD Stages 3B and above (defined as estimated GFR less than or equal to 44 mL/min/1.73m2 with evidence of kidney damage) AND diagnosed with * one or more of the following sub-optimally managed parameters pertaining to blood pressure control OR, glycemic control OR fluid status management. Exclusion criteria: * Pregnancy * End stage kidney disease * Enrolment in any structured outpatient-based or community-based CKD program for at least six months prior to or during the period of enrolment in the study. * Dementia and/or cognitive impairment
๐Ÿ’Š

What it tests

  • INTEGREAT-CKD Intervention
๐Ÿ“

Where

1 site
Wei Zhen Hong
Singapore, Singapore
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy